Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capravirine with Kaletra and NRTIs in Treatment-Experienced HIV
NCT00052117Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of capravirine in human immunodeficiency virus infection (HIV), sponsored by Pfizer. Started Jan 2003; status: completed.
02
Drugs
capravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00052117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052117.